Information-driven protein-DNA docking using HADDOCK: it is a matter of flexibility

Area of Science:

• Structural Biology
• Computational Biology
• Biochemistry

Background:

• Protein-DNA interactions are crucial in biological processes but challenging to model due to DNA's intrinsic flexibility.
• Existing protein-DNA docking methods often struggle to accurately represent DNA's dynamic nature.
• Developing accurate computational models for protein-DNA complex formation is essential for understanding gene regulation and developing therapeutics.

Purpose of the Study:

• To extend the HADDOCK (High Ambiguity Driven DOCKing) method to explicitly account for DNA flexibility in protein-DNA docking.
• To develop a robust computational approach for predicting the structure of protein-DNA complexes.
• To validate the enhanced HADDOCK method using well-characterized repressor-DNA complexes.

Main Methods:

• Modified the HADDOCK protocol to include flexibility for all DNA nucleotides and protein interface residues during refinement stages.
• Employed a two-stage docking strategy: an initial docking run followed by a second round using pre-bent and twisted DNA structures generated from the first.
• Utilized non-structural experimental data to guide the docking process.

Main Results:

• The enhanced HADDOCK method successfully predicted the spatial arrangement and specific DNA conformations for bacteriophage 434 Cro, E. coli Lac headpiece, and bacteriophage P22 Arc complexes.
• Starting from unbound protein and DNA structures, the method accurately reproduced published complex conformations.
• The two-stage approach yielded top-ranking solutions with high similarity to experimentally determined structures.

Conclusions:

• The extended HADDOCK method effectively models protein-DNA complexes by addressing DNA flexibility.
• This two-stage docking approach enables accurate prediction of complex structures from unbound components.
• The method provides a valuable tool for studying protein-DNA interactions and facilitating drug discovery.